Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Kirsten Utpatel, Sabine Einhell et al.|BMC Medicine|2026Cited by 2
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Christian Werno, Florian Lüke et al.|Molecular Oncology|2024Cited by 1
Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Kirsten Utpatel, Simon Mellin et al.|Open MIND|2026Cited by 0